32
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Introducing a Modern Chemotherapeutic Drug Formulated by Etlingera velutina Essential Oil for the Treatment of Human Gastric Cancer

, , , , &
Pages 967-975 | Received 08 Jan 2022, Accepted 11 Sep 2022, Published online: 30 Nov 2022
 

Abstract

The essential oils from the stem of Etlingera velutina was obtained by a Clevenger-apparatus and the chemical composition of the volatile oil was identified using GC-FID and GC-MS methods. the oil consists of sesquiterpene hydrocarbon. α-Cubebene (29.98%) and 2-undecanone (20.04%) were the main components for the rhizome oil. In the cellular and molecular part of this study, the MTT assay was run to treat of the cell lines by EO for evaluation of the cytotoxicity and anti-human gastric cancer properties of EO. The results revealed a dose-dependently on the viability of malignant gastric cell line. The IC50 of EO were 376 and 371 μg/mL against NCI-N87 and MKN45 cell lines, respectively. For antioxidant analysis, the IC50 of 192 μg/mL was obtained for radical scavenging activity of EO against DPPH.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.